Androgen receptor inhibitor-induced "BRCAness" and PARP inhibition are synthetically lethal for castration-resistant prostate cancer.
Sci Signal. 2017 May 23;10(480):eaam7479. doi: 10.1126/scisignal.aam7479.
Sci Signal. 2017.
PMID: 28536297
Free PMC article.